VanEck Pharmaceutical ETF PPH
Set alert
119.21 USD -0.12 -0.10%
At close · Nov 2
119.25 +0.04 +0.03%
After hours · Nov 2, 5:16 PM ET
118.40 Day range 119.72
91.67 52-week range 120.86
- YTD
- +15.55%
- 1 year
- +28.82%
- Open
- 118.84
- Prev close
- 119.33
- Mkt cap
- 1.10B
- Vol
- 172.63K
- Avg vol
- 323.40K
- EPS
- 4.37
- P/E
- 27.25
- Div yield
- 0.00%
More statistics
- Low
- 118.40
- High
- 119.72
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 112.59
- 200-d avg
- 107.91
1Y chart
Events in this range
- Dec 29, 2025Dividend: 0.3106
- Apr 1, 2026Dividend: 0.8441
- Jul 1, 2026Dividend: 0.6248
- Oct 1, 2026Dividend: 0.36
Signals (40)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 14, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 9, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| SMA: Bullish | Sep 22, 2026 | 1 month ago |
| SMA: Bearish | Sep 18, 2026 | 1 month ago |
| SMA: Bullish | Sep 17, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 28, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 18, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 12, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 11, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 3, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 27, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 13, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 25, 2026 | 4 months ago |
| SMA: Bullish | Jun 22, 2026 | 4 months ago |
| SMA: Bearish | Jun 18, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 17, 2026 | 4 months ago |
| SMA: Bullish | Jun 4, 2026 | 5 months ago |
| MACD: Buy Signal | Jun 4, 2026 | 5 months ago |
| MACD: Sell Signal | Jun 3, 2026 | 5 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | May 19, 2026 | 5 months ago |
| MACD: Buy Signal | May 12, 2026 | 5 months ago |
| MACD: Sell Signal | May 11, 2026 | 5 months ago |
| MACD: Buy Signal | May 4, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 22, 2026 | 6 months ago |
| MACD: Buy Signal | Mar 31, 2026 | 7 months ago |
| RSI: Oversold | Mar 20, 2026 | 7 months ago |
| SMA: Bearish | Mar 5, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 23, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 4, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 15, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 7, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 2, 2026 | 10 months ago |
| MACD: Buy Signal | Dec 22, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 3, 2025 | 11 months ago |
| RSI: Overbought | Nov 21, 2025 | 11 months ago |
| RSI: Overbought | Nov 11, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 6, 2025 | 12 months ago |
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 27.25
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 112.59
- 200-day average
- 107.91
About VanEck Pharmaceutical ETF
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
News
- Can GLP-1s Fatten Your Portfolio? We Examine the VanEck Pharmaceutical ETF vs State Street SPDR Pharmaceuticals ETF
- PPH: Key Pharmaceutical Innovations Support Bullish Outlook (Upgrade)
- Which Pharmaceutical ETF Is the Better Buy: iShares’ Domestic IHE or VanEck’s Global PPH?
- Which Healthcare ETF Is the Better Buy: Simplify's Active PINK or VanEck's Pharma-Focused PPH?
- Execution of Pharma Tariffs Brings These ETFs Into Focus
- Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
- Better Pharmaceuticals ETF: VanEck's PPH vs. Invesco PJP
- VanEck Pharmaceutical ETF vs VanEck Biotech ETF: Which Fund Is Better for Drug Innovation Profits?
- Should You Bet Big on Drugmakers? VanEck Pharmaceutical ETF vs.
- Healthcare ETFs to Watch Post Merck-Moderna Cancer Vaccine Breakthrough
Your note
Sign in to keep a note on PPH — it syncs with the Stock Master app.